[go: up one dir, main page]

CN201551639U - A dual-chamber fluid reservoir for a bioartificial liver support system - Google Patents

A dual-chamber fluid reservoir for a bioartificial liver support system Download PDF

Info

Publication number
CN201551639U
CN201551639U CN200920201694XU CN200920201694U CN201551639U CN 201551639 U CN201551639 U CN 201551639U CN 200920201694X U CN200920201694X U CN 200920201694XU CN 200920201694 U CN200920201694 U CN 200920201694U CN 201551639 U CN201551639 U CN 201551639U
Authority
CN
China
Prior art keywords
cavity
support system
chamber
liquid
storage tank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN200920201694XU
Other languages
Chinese (zh)
Inventor
李兰娟
赵立夫
张安业
吕国良
朱春侠
陈佳佳
潘小平
章益民
喻成波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN200920201694XU priority Critical patent/CN201551639U/en
Application granted granted Critical
Publication of CN201551639U publication Critical patent/CN201551639U/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Landscapes

  • External Artificial Organs (AREA)

Abstract

本实用新型公开了一种生物人工肝支持系统用双腔储液池,包括内腔和外腔;其中,外腔顶部设有第一液体进口和第一气压平衡孔,内腔顶部设有第二液体进口和第二气压平衡孔,内腔底部设有第一液体出口,内腔侧壁靠近底部设有第二液体出口,该第二液体出口借助一管状通道途经外腔,由内腔直接通往双腔储液池外,该管状通道在外腔部分的侧壁上设置有若干个外腔侧孔;本实用新型的生物人工肝支持系统用双腔储液池实现了重肝血浆多次流经生物反应器,形成高效循环通路,从而可以发挥出更佳的治疗效果。本实用新型提供的生物人工肝支持系统用双腔储液池还可根据临床的具体实践要求,对内外双腔容积大小比例进行重新设置,扩大或缩小,从而更加合理地应用于临床。

Figure 200920201694

The utility model discloses a double-cavity liquid storage tank for a bioartificial liver support system, which includes an inner cavity and an outer cavity; wherein, the top of the outer cavity is provided with a first liquid inlet and a first air pressure balance hole, and the top of the inner cavity is provided with a second cavity. Two liquid inlets and a second air pressure balance hole, the bottom of the inner cavity is provided with a first liquid outlet, and the side wall of the inner cavity is provided with a second liquid outlet near the bottom. Leading to the outside of the double-chamber liquid storage pool, the tubular channel is provided with several external chamber side holes on the side wall of the outer chamber part; the bioartificial liver support system of the present utility model uses the double-chamber liquid storage pool to realize multiple hepatic plasma It flows through the bioreactor to form a highly efficient circulation path, so that it can exert a better therapeutic effect. The dual-chamber fluid storage tank for the bioartificial liver support system provided by the utility model can also be reset, enlarged or reduced in proportion to the volume of the inner and outer double chambers according to specific clinical practice requirements, so that it can be more reasonably used in clinical practice.

Figure 200920201694

Description

一种生物人工肝支持系统用双腔储液池 A dual-chamber fluid reservoir for a bioartificial liver support system

技术领域technical field

本实用新型属于生物医学技术领域,涉及一种医疗设备,尤其涉及一种应用于生物人工肝治疗,可有效提高生物人工肝治疗效果的重要装置:生物人工肝支持系统用双腔储液池。The utility model belongs to the technical field of biomedicine and relates to a medical device, in particular to an important device which is applied to the treatment of a bioartificial liver and can effectively improve the treatment effect of the bioartificial liver: a double-chamber fluid storage pool for a bioartificial liver support system.

背景技术Background technique

当前,肝衰竭病情危重,进展迅速,病死率极高,针对肝衰竭的治疗一直是世界性难题。而目前人工肝治疗已经成为重型肝炎肝衰竭一个不可替代的治疗手段,尤其是生物人工肝在理论上可以代偿肝脏的全部功能,代表着今后人工肝的发展潮流,面临着巨大的临床需求,具有着广泛的临床应用前景。生物人工肝的基本原理是患者的血液或血浆流经载有生物活性细胞的生物反应器,在此过程中,生物活性细胞一方面完成血液(血浆)中毒性物质的代谢,同时将其合成的生物活性物质释放入血,纠正内环境紊乱,暂时替代衰竭肝脏的部分功能,为自体肝脏恢复或肝移植赢得机会,从而降低患者死亡率,达到治疗目的。At present, liver failure is a critical condition with rapid progress and high mortality rate. The treatment of liver failure has always been a worldwide problem. At present, the artificial liver treatment has become an irreplaceable treatment for severe hepatitis liver failure, especially the bioartificial liver can theoretically compensate all the functions of the liver, which represents the development trend of artificial liver in the future and is facing a huge clinical demand. It has broad clinical application prospects. The basic principle of the bioartificial liver is that the patient's blood or plasma flows through the bioreactor loaded with bioactive cells. During this process, the bioactive cells complete the metabolism of toxic substances in the blood (plasma) and simultaneously synthesize the Biologically active substances are released into the blood, correct internal environment disorders, temporarily replace part of the function of the failed liver, and win opportunities for autologous liver recovery or liver transplantation, thereby reducing patient mortality and achieving therapeutic purposes.

不难理解,生物人工肝的疗效除取决于反应器内肝细胞的数量和生物学功能外,患者血液(血浆)与体外培养细胞之间的物质交换效率也成为影响疗效的重要因素,设计合理的储液池在这一环节起着关键作用。国外已进行I-III期临床验证的生物人工肝装置有BLSS、AMC-BAL、ELAD、MELS、HepatAssist等,多未达到预期的临床疗效。究其原因,很重要的一个方面在于它们虽着眼于对细胞源和反应器表征的研究,但对储液池这一组件未进行充分的研究。缺少储液池的人工肝装置导致患者血液(血浆)经过一次循环后即返回体内,这使得患者血液(血浆)与细胞间缺乏充分的物质交换,生物人工肝治疗效率低下。多数人工肝装置配备了储液池,但大多为单腔结构,尽管可实现多次循环,其结构的缺陷无法避免未流经反应器的血液(血浆)直接回输体内的情况,即形成所谓无效循环。It is not difficult to understand that the curative effect of the bioartificial liver depends not only on the number and biological function of the hepatocytes in the reactor, but also on the material exchange efficiency between the patient's blood (plasma) and the cultured cells in vitro. The liquid reservoir plays a key role in this link. The bioartificial liver devices that have undergone phase I-III clinical verification in foreign countries include BLSS, AMC-BAL, ELAD, MELS, HepatAssist, etc., and most of them have not achieved the expected clinical efficacy. An important reason for this is that although they focus on the research on the cell source and the characterization of the reactor, the component of the liquid reservoir has not been fully studied. The artificial liver device lacking a liquid reservoir causes the patient's blood (plasma) to return to the body after one cycle, which makes the patient's blood (plasma) lack sufficient material exchange with the cells, and the treatment efficiency of the bioartificial liver is low. Most artificial liver devices are equipped with liquid reservoirs, but most of them are single-chamber structures. Although multiple cycles can be achieved, the structural defects cannot avoid the situation that the blood (plasma) that has not passed through the reactor is directly returned to the body, that is, the so-called Invalid loop.

实用新型内容Utility model content

本实用新型的目的在于针对现有技术的不足,提供一种生物人工肝支持系统用双腔储液池,本实用新型适用于生物人工肝治疗,可以将重肝血浆多次流经生物反应器,形成高效循环通路,起到更佳的治疗效果。The purpose of this utility model is to provide a dual-chamber liquid storage tank for a bioartificial liver support system in view of the deficiencies of the prior art. , form a highly efficient circulation pathway, and play a better therapeutic effect.

本实用新型的目的是通过以下技术方案来实现的:一种生物人工肝支持系统用双腔储液池,包括内腔和外腔;其中,外腔顶部设有第一液体进口和第一气压平衡孔,内腔顶部设有第二液体进口和第二气压平衡孔,内腔底部设有第一液体出口,内腔侧壁靠近底部设有第二液体出口,该第二液体出口借助一管状通道途经外腔,由内腔直接通往双腔储液池外,该管状通道在外腔部分的侧壁上设置有若干个外腔侧孔。The purpose of this utility model is achieved through the following technical solutions: a dual-chamber liquid storage pool for a bioartificial liver support system, including an inner chamber and an outer chamber; wherein, the top of the outer chamber is provided with a first liquid inlet and a first air pressure A balance hole, the top of the inner cavity is provided with a second liquid inlet and a second air pressure balance hole, the bottom of the inner cavity is provided with a first liquid outlet, and the side wall of the inner cavity is provided with a second liquid outlet near the bottom, and the second liquid outlet is provided with a tubular The channel passes through the outer cavity, and the inner cavity directly leads to the outside of the double-chamber liquid storage pool. The tubular channel is provided with several outer cavity side holes on the side wall of the outer cavity.

进一步地,所述内腔和外腔由两个顶部和底部密封的同心等高空心圆柱体组成,材料为塑料或有机玻璃。Further, the inner cavity and the outer cavity are composed of two concentric and equal-height hollow cylinders sealed at the top and bottom, and the material is plastic or plexiglass.

进一步地,所述第一气压平衡孔和第二气压平衡孔的半径为0.3cm,均内设滤膜。Further, the first air pressure balance hole and the second air pressure balance hole have a radius of 0.3 cm, and filter membranes are provided inside.

进一步地,所述滤膜厚为0.22微米,其材料为混合纤维素酯。Further, the thickness of the filter membrane is 0.22 microns, and its material is mixed cellulose ester.

进一步地,所述外腔侧孔7有三个,直径为0.15cm。Further, there are three outer cavity side holes 7 with a diameter of 0.15 cm.

本实用新型的有益效果是,本实用新型的生物人工肝支持系统用双腔储液池实现了重肝血浆多次流经生物反应器,形成高效循环通路,从而可以发挥出更佳的治疗效果。本实用新型提供的生物人工肝支持系统用双腔储液池还可根据临床的具体实践要求,对内外双腔容积大小比例进行重新设置,扩大或缩小,从而更加合理地应用于临床。The beneficial effect of the utility model is that the bioartificial liver support system of the utility model uses a double-chamber liquid storage tank to realize the heavy liver plasma flowing through the bioreactor multiple times to form a high-efficiency circulation path, so that a better therapeutic effect can be exerted . The dual-chamber fluid storage tank for the bioartificial liver support system provided by the utility model can also be reset, enlarged or reduced in proportion to the volume of the inner and outer double chambers according to specific clinical practice requirements, so that it can be more reasonably used in clinical practice.

附图说明Description of drawings

图1为生物人工肝支持系统用双腔储液池的立体结构示意图;FIG. 1 is a schematic diagram of a three-dimensional structure of a dual-chamber fluid storage tank for a bioartificial liver support system;

图2为生物人工肝支持系统用双腔储液池外接系统辅助装置的示意图。Fig. 2 is a schematic diagram of an external system auxiliary device for a dual-chamber fluid reservoir used in a bioartificial liver support system.

具体实施方式Detailed ways

下面根据附图详细描述本实用新型,本实用新型的目的和效果将变得更加明显。The utility model is described in detail below according to the accompanying drawings, and the purpose and effect of the utility model will become more obvious.

如图1所示,本实用新型的生物人工肝支持系统用双腔储液池,包括同心等高的内腔8和外腔9、第一液体进口1、第二液体进口2、第一气压平衡孔4、第二气压平衡孔3、第一液体出口5、第二液体出口6、外腔侧孔7。储液池总体外型由两个同心等高圆柱体组成,池内相应分为密闭的内外双腔。储液池上顶部的第一液体进口1和第一气压平衡孔4均连通内腔8,第二液体进口2和第二气压平衡孔3均连通外腔9。第一气压平衡孔4和第二气压平衡孔3分别将内腔8、外腔9与池外连通,保持池内外大气压平衡,并且气压平衡孔在孔内均设置0.22微米的滤膜,保证池内无菌状态,滤膜材料可为混合纤维素酯等。As shown in Figure 1, the dual-chamber fluid reservoir for the bioartificial liver support system of the present invention includes a concentric and equal-height inner chamber 8 and an outer chamber 9, a first liquid inlet 1, a second liquid inlet 2, a first air pressure Balance hole 4, second air pressure balance hole 3, first liquid outlet 5, second liquid outlet 6, outer chamber side hole 7. The overall appearance of the reservoir is composed of two concentric cylinders of equal height, and the interior of the reservoir is correspondingly divided into closed inner and outer double cavities. Both the first liquid inlet 1 and the first air pressure balance hole 4 on the upper top of the reservoir are connected to the inner chamber 8 , and the second liquid inlet 2 and the second air pressure balance hole 3 are both connected to the outer chamber 9 . The first air pressure balance hole 4 and the second air pressure balance hole 3 respectively connect the inner cavity 8 and the outer cavity 9 with the outside of the pool to maintain the balance of atmospheric pressure inside and outside the pool, and the air pressure balance holes are equipped with 0.22 micron filter membranes in the holes to ensure that the inside and outside of the pool In sterile state, the filter membrane material can be mixed cellulose ester and the like.

储液池下底部有第一液体出口5,作为净化后血浆返回人体的通路。侧壁靠近下底部第一液体出口6,该出口借助一管状通道途经外腔9,由内腔8直接通往储液池外,而该通道在外腔9部分的侧壁上设置有若干个外腔侧孔7,直径约0.15cm,图中为3个。There is a first liquid outlet 5 at the lower bottom of the liquid storage tank, which serves as a passage for the purified plasma to return to the human body. The side wall is close to the first liquid outlet 6 at the lower bottom. The outlet passes through the outer chamber 9 by means of a tubular passage, and directly leads to the outside of the liquid storage tank from the inner chamber 8, and the passage is provided with several outer chambers on the side wall of the outer chamber 9. The cavity side holes 7 are about 0.15cm in diameter, and there are three in the figure.

外腔9将由第一液体进口1容纳来自人体的重肝血浆,而内腔8则由第二液体进口2容纳与生物反应器作用后的净化血浆。第一液体进口1连接血浆分离器10的管道,由泵带动,不断经第一液体进口1向储液池外腔9内泵入重肝血浆;第二液体进口2则连接生物反应器11的管道,重肝血浆与部分循环的血浆在生物反应器11中与肝细胞相互作用后,由泵带动,经第二液体进口2作为净化后血浆返回储液池内腔8。该储液池上顶部有两处气压平衡孔,孔半径约为0.3cm,分别将内腔8、外腔9与池外连通,从而保持池内外大气压平衡,并且该两处气压平衡孔在孔内设置0.22微米的滤膜,从而可保持储液池内无菌状态。储液池下底部有第一液体出口5,接通内腔8,并向外连接返回人体的血浆管道。储液池内腔8中部分净化后的血浆可经第一液体出口5,返回人体。其中,由第一液体进口1进入外腔9的重肝血浆量,与由第一液体出口5经内腔8流出的净化后的血浆量保持均等。储液池侧壁靠近下底部有第二液体出口6,该液体出口6借助一管状通道,由内腔8直接通往储液池外,而该通道在途径外腔9部分的侧壁上设置有外腔侧孔7,共设3孔,每孔的直径约0.15cm。第二液体出口6将连通生物反应器的管道,由泵带动,内腔8的净化后血浆将经第二液体出口6进入生物反应器的管道,而外腔9的重肝血浆将由外腔侧孔7被抽吸经液体出口6与内腔8净化后的血浆相混合,一并进入生物反应器11,与生物反应器11中的肝细胞相互作用后,最后经第二液体进口2返回内腔8,形成一次循环。以上液体进口及液体出口的管径设置,均为每管的直径约0.6cm,另外,储液池外部分的长度为1.5cm。The outer cavity 9 will contain heavy liver plasma from the human body through the first liquid inlet 1 , while the inner cavity 8 will contain the purified plasma after acting with the bioreactor through the second liquid inlet 2 . The first liquid inlet 1 is connected to the pipeline of the plasma separator 10, and is driven by the pump to continuously pump heavy liver plasma into the outer cavity 9 of the reservoir through the first liquid inlet 1; the second liquid inlet 2 is connected to the bioreactor 11 After the pipeline, heavy liver plasma and part of the circulating plasma interact with the liver cells in the bioreactor 11, they are driven by the pump and returned to the inner chamber 8 of the storage pool as purified plasma through the second liquid inlet 2. There are two air pressure balance holes on the top of the liquid storage tank, the hole radius is about 0.3cm, which respectively connect the inner chamber 8 and the outer chamber 9 with the outside of the pool, so as to maintain the balance of atmospheric pressure inside and outside the pool, and the two air pressure balance holes are in the hole A 0.22-micron filter membrane is set to maintain a sterile state in the reservoir. There is a first liquid outlet 5 at the lower bottom of the liquid storage pool, which is connected to the inner chamber 8 and connected outward to the plasma pipeline returning to the human body. The partially purified plasma in the inner cavity 8 of the liquid storage pool can return to the human body through the first liquid outlet 5 . Wherein, the amount of hepatic heavy plasma entering the outer cavity 9 from the first liquid inlet 1 is equal to the amount of purified plasma flowing out from the first liquid outlet 5 through the inner cavity 8 . The side wall of the liquid reservoir has a second liquid outlet 6 near the lower bottom, and the liquid outlet 6 leads directly to the outside of the liquid reservoir from the inner cavity 8 by means of a tubular channel, and the channel is provided on the side wall of the part passing through the outer cavity 9 There are 3 holes in the outer cavity side hole 7, and the diameter of each hole is about 0.15cm. The second liquid outlet 6 will be connected to the pipeline of the bioreactor, driven by the pump, the purified plasma in the inner cavity 8 will enter the pipeline of the bioreactor through the second liquid outlet 6, and the heavy liver plasma in the outer cavity 9 will be discharged from the outer cavity side. The hole 7 is sucked through the liquid outlet 6 and mixed with the purified plasma in the inner cavity 8, and enters the bioreactor 11 together, interacts with the liver cells in the bioreactor 11, and finally returns to the inner cavity through the second liquid inlet 2 Cavity 8 forms a circulation. The pipe diameters of the above liquid inlet and liquid outlet are all about 0.6 cm in diameter. In addition, the length of the outer part of the liquid storage tank is 1.5 cm.

本实用新型提供的生物人工肝支持系统用双腔储液池,由内外双腔组成,借助于第二液体出口6及外腔侧孔7,在泵的带动下,可以同时吸取内外双腔的血浆,并可形成多次有效的生物人工肝治疗循环,避免了重肝血浆未经生物反应器与肝细胞反应直接返回体内,从而更加高效地发挥生物人工肝治疗作用。The dual-chamber liquid storage tank for the bioartificial liver support system provided by the utility model is composed of inner and outer double chambers. With the help of the second liquid outlet 6 and the side hole 7 of the outer chamber, driven by the pump, it can simultaneously absorb liquid from the inner and outer double chambers. Plasma can form multiple effective bioartificial liver treatment cycles, avoiding the direct return of heavy liver plasma to the body without reacting with the bioreactor and liver cells, so as to play the role of bioartificial liver treatment more efficiently.

本实例生物人工肝支持系统用双腔储液池的外壳材料可为塑料或有机玻璃,大小尺寸为:储液池内腔8半径为3cm,外腔9半径为4cm,均除去壁厚,池高为9cm,内腔8容积约250ml,外腔9容积约200ml。实际制作时可根据临床实践需要放大或缩小,制定出最佳的尺寸。The shell material of the double-chamber reservoir for the bioartificial liver support system of this example can be plastic or plexiglass, and its size is: the radius of the inner chamber 8 of the reservoir is 3 cm, and the radius of the outer chamber 9 is 4 cm. It is 9cm, the volume of inner chamber 8 is about 250ml, and the volume of outer chamber 9 is about 200ml. During actual production, it can be enlarged or reduced according to the needs of clinical practice, and the optimal size can be worked out.

如图2所示:重肝血液从病人静脉由泵抽出,进入血浆分离器10,重肝血液分离成为重肝血浆和血细胞,重肝血浆将由第一液体进口1,进入储液池12的外腔9中。由于池外生物反应器通路中泵的抽吸作用,外腔9中的重肝血浆将通过第二液体出口6在外腔9部分通道的外腔侧孔7,经第二液体出口6流出进入装有肝细胞的生物反应器11内,与肝细胞相互作用。进行第一次相互作用后的血浆作为净化血浆将通过第一液体进口2进入储液池12的内腔8,与内腔8内已经预充的代血浆相互混合,稀释后的净化血浆大部分将通过第二液体出口6再次由泵带动进入生物反应器11与肝细胞相互作用,形成重肝血浆反复多次进入生物反应器11的循环。经历过多次循环进入生物反应器11充分作用后的净化血浆将由第一液体出口5,由泵带动,进入返回人体的管路,并最终与血细胞相互混合后返回人体。As shown in Figure 2: the hepatic blood is pumped out from the patient's vein and enters the plasma separator 10. The hepatic blood is separated into hepatic plasma and blood cells. Cavity 9. Due to the pumping effect of the pump in the bioreactor passage outside the pool, the heavy liver plasma in the outer cavity 9 will flow out through the second liquid outlet 6 through the outer cavity side hole 7 of the outer cavity 9 part passage, and enter the device through the second liquid outlet 6. In the bioreactor 11 with hepatocytes, interact with the hepatocytes. After the first interaction, the plasma, as purified plasma, will enter the inner chamber 8 of the reservoir 12 through the first liquid inlet 2, and mix with the prefilled plasma generation in the inner chamber 8, and most of the diluted purified plasma It will pass through the second liquid outlet 6 and be driven by the pump again into the bioreactor 11 to interact with the liver cells, forming a cycle in which heavy liver plasma enters the bioreactor 11 repeatedly. The purified plasma that has gone through multiple cycles into the bioreactor 11 will be driven by the pump through the first liquid outlet 5, and enter the pipeline returning to the human body, and finally mix with blood cells and return to the human body.

本实用新型为生物人工肝支持系统用双腔储液池,与普通循环储液池相比,有着巨大的优势。普通的储液池仅仅为一有着数个液体进出通道的密闭立体瓶,重肝血浆进入普通储液池后,不能与净化后的血浆相互隔离,而是直接混合在一起,部分混合后的血浆将直接返回人体,从而造成了部分重肝血浆未经生物反应器与肝细胞相互作用,即直接返回体内,起不到生物人工肝的治疗效果。而本实用新型所提供的生物人工肝支持系统用双腔储液池,由内外双腔组成,外腔容纳重肝血浆,内腔容纳净化后的血浆,保证了两部分血浆的有效隔离。同时,本储液池借助于特殊设置的液体出口及外腔侧孔,在泵的带动下,可以同时吸取内外双腔的血浆,而由于泵向外的抽吸作用,外腔中的重肝血浆将与内腔中的已净化后的血浆一起抽吸进入生物反应器,而不会向内直接进入内腔,从而有效避免了重肝血浆未经生物反应器与肝细胞反应直接返回体内。而内腔中净化后的血浆及部分外腔的重肝血浆不断形成多次有效的生物人工肝治疗循环,更为高效地发挥生物人工肝的治疗效果。另外,与普通储液池相比,本实用新型还通过设置带有0.22微米滤膜的气压平衡孔,一并有效地解决池内外气压平衡问题及保持池内的无菌状态,从而在气压动力学及生物安全方面体现出独特的优势。The utility model is a double-cavity liquid storage pool for a bioartificial liver support system, and has huge advantages compared with common circulation liquid storage pools. Ordinary liquid reservoirs are only a closed three-dimensional bottle with several channels for liquid in and out. After the heavy liver plasma enters the ordinary liquid reservoir, it cannot be isolated from the purified plasma, but directly mixed together, and part of the mixed plasma It will be directly returned to the human body, resulting in part of the hepatic plasma directly returning to the body without the interaction between the bioreactor and the liver cells, which will not achieve the therapeutic effect of the bioartificial liver. However, the dual-chamber fluid storage tank for the bioartificial liver support system provided by the utility model is composed of an inner and outer double chamber, the outer chamber holds heavy liver plasma, and the inner chamber holds purified plasma, which ensures the effective isolation of the two parts of plasma. At the same time, with the help of the specially set liquid outlet and the side hole of the outer chamber, the liquid storage pool can absorb the plasma of the inner and outer double chambers at the same time under the drive of the pump, and due to the outward suction of the pump, the heavy liver in the outer chamber Plasma will be pumped into the bioreactor together with the purified plasma in the inner cavity, and will not directly enter the inner cavity, thus effectively preventing heavy liver plasma from returning directly to the body without reacting with the bioreactor and liver cells. The purified plasma in the inner cavity and part of the liver-heavy plasma in the outer cavity continuously form multiple effective bioartificial liver treatment cycles, and more efficiently exert the therapeutic effect of the bioartificial liver. In addition, compared with the ordinary liquid storage tank, the utility model also effectively solves the problem of air pressure balance inside and outside the tank and maintains the aseptic state in the tank by setting the air pressure balance hole with a 0.22 micron filter membrane, so that the air pressure dynamics And biological security reflects a unique advantage.

本生物人工肝支持系统用双腔储液池,通过独特的构造,可有效提高生物人工肝治疗效率,并且设计合理,功能全面,适用性强,应用范围广泛,具有很好的应用前景。The bioartificial liver support system uses a double-chamber fluid storage pool, which can effectively improve the treatment efficiency of the bioartificial liver through a unique structure, and has reasonable design, comprehensive functions, strong applicability, wide application range, and good application prospects.

Claims (5)

1. a dual-cavity liquid storage tank for biological artificial liver support system is characterized in that, comprises inner chamber (8) and exocoel (9); Wherein, exocoel (9) top is provided with first liquid-inlet (1) and first air equalizer opening (4), inner chamber (8) top is provided with second liquid-inlet (2) and second air equalizer opening (3), inner chamber (8) bottom is provided with first liquid outlet (5), inner chamber (8) sidewall is provided with second liquid outlet (6) near the bottom, this second liquid outlet (6) by a tubular conduit by way of exocoel (9), directly led to outside the dual-cavity liquid storage tank by inner chamber (8), the sidewall of this tubular conduit exocoel (9) part is provided with several exocoel side openings (7).
2. according to the described dual-cavity liquid storage tank for biological artificial liver support system of claim 1, it is characterized in that described inner chamber (8) and exocoel (9) are made up of the concentric contour hollow cylinder of two tops and bottom sealing, material is plastics or lucite.
3. according to the described dual-cavity liquid storage tank for biological artificial liver support system of claim 1, it is characterized in that the radius of described first air equalizer opening (4) and second air equalizer opening (3) is 0.3cm, establish filter membrane in all.
4. according to the described dual-cavity liquid storage tank for biological artificial liver support system of claim 3, it is characterized in that described filter membrane is thick to be 0.22 micron, its material is a mixed cellulose ester.
5. according to the described dual-cavity liquid storage tank for biological artificial liver support system of claim 1, it is characterized in that described exocoel side opening (7) has three, diameter is 0.15cm.
CN200920201694XU 2009-12-14 2009-12-14 A dual-chamber fluid reservoir for a bioartificial liver support system Expired - Lifetime CN201551639U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200920201694XU CN201551639U (en) 2009-12-14 2009-12-14 A dual-chamber fluid reservoir for a bioartificial liver support system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200920201694XU CN201551639U (en) 2009-12-14 2009-12-14 A dual-chamber fluid reservoir for a bioartificial liver support system

Publications (1)

Publication Number Publication Date
CN201551639U true CN201551639U (en) 2010-08-18

Family

ID=42611312

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200920201694XU Expired - Lifetime CN201551639U (en) 2009-12-14 2009-12-14 A dual-chamber fluid reservoir for a bioartificial liver support system

Country Status (1)

Country Link
CN (1) CN201551639U (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732770B (en) * 2009-12-14 2012-04-25 浙江大学 Double-cavity liquid storage tank for biological artificial liver support system
CN103263704A (en) * 2013-05-09 2013-08-28 浙江大学 Plasma exchanging adsorption filtration purification system provided with plasma storage bag and application method of purification system

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732770B (en) * 2009-12-14 2012-04-25 浙江大学 Double-cavity liquid storage tank for biological artificial liver support system
CN103263704A (en) * 2013-05-09 2013-08-28 浙江大学 Plasma exchanging adsorption filtration purification system provided with plasma storage bag and application method of purification system
CN103263704B (en) * 2013-05-09 2015-10-28 浙江大学 Be equipped with the plasmapheresis absorption filtration cleaning system of slurry storing bag

Similar Documents

Publication Publication Date Title
CN101732770A (en) Dual-cavity liquid storage tank for biological artificial liver support system
CN101732771B (en) Cell reactor and artificial liver support system comprising same
CN103877631A (en) Bioartificial liver system
CN103170021A (en) Deflector-type micro-capsule suspension type fluidized bed bioreactor for artificial liver
CN100544684C (en) Microcapsule Suspension Fluidized Bed Bioreactor for Artificial Liver
CN101709266B (en) Bioreactor
CN106139289B (en) Semi-permeable membrane is layered integrated biological reactor
CN105505775A (en) Extracorporeal liver support system
CN101549179A (en) Perforated brick type filling support type reactor used in artificial liver
CN201551639U (en) A dual-chamber fluid reservoir for a bioartificial liver support system
CN101559246B (en) Hybrid artificial liver support system equipped with nano fibre sheet stacked reactor
WO2012122719A1 (en) Hepatic lobule-like bioreactor
CN201418905Y (en) Fiber mesh stacked bioreactor for artificial liver
CN101381678B (en) Multi-layer diaphragm structure perfusion bioreactor and application
CN102091360A (en) Reciprocally turning perfusion bioreactor for biological artificial liver and processing method thereof
CN201871013U (en) Bioartificial liver support system and combined liquid storage tank
WO2024183294A1 (en) Cell processing device and cell processing method
CN110448749A (en) Cell-circulating bioartificial liver device with oxygen supply
CN2638736Y (en) Heterozygous artificial liver supporting device
US11400199B2 (en) Bioartificial liver based on human iPSCs-derived hepatocyte-like cells and multilayer porous bioreactor
CN201999942U (en) Biological reaction container and back-and-forth turnover perfusion bioreactor for bioartificial liver
CN210812952U (en) Cell cycle bioartificial liver device with oxygen supply
CN212833765U (en) Perfusion type bioreactor for bioartificial liver
CN202096521U (en) Integrated type micro-sac suspension type fluidized bed bio-reactor
CN101966352B (en) Bioartificial liver support system and combined type liquid storage tank thereof

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
AV01 Patent right actively abandoned

Granted publication date: 20100818

Effective date of abandoning: 20091214